Cargando…

Urinary biomarker for the detection of recurrence following non-muscle invasive bladder cancer: are we there yet?

Detalles Bibliográficos
Autores principales:	Tan, Wei Shen, Tan, Wei Phin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881187/ https://www.ncbi.nlm.nih.gov/pubmed/29644175 http://dx.doi.org/10.21037/tau.2017.12.18

Ejemplares similares

Biomarkers in Alzheimer disease: are we there yet?
por: Generoso, Jaqueline S., et al.
Publicado: (2020)

Are we there yet?
por: McCann, Shaun R.
Publicado: (2022)

Pyroptosis-related signatures in bladder cancer prognosis and treatment—are we there yet?
por: Kołat, Damian, et al.
Publicado: (2022)

Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer
por: Loras, Alba, et al.
Publicado: (2019)

Standardized urine biomarkers in assessing neonatal kidney function: are we there yet?()
por: Mak, Robert H., et al.
Publicado: (2021)

Regenerative medicine: are we there yet?
por: Badylak, Stephen, et al.
Publicado: (2017)

Precision Oncology: Are We There Yet?
Publicado: (2017)

Artificial intelligence as an adjunct tool for breast oncologists – are we there yet?
por: Schlam, I., et al.
Publicado: (2023)

Personalized medicine for asthma: Are we there yet?
por: Poon, Audrey H., et al.
Publicado: (2012)

The COVID‐19 world – Are we there yet?
por: Hamamoto, Yoshiyuki
Publicado: (2021)

Value of Information Analysis: Are We There Yet?
por: Tuffaha, Haitham
Publicado: (2020)

Biomarkers for SUDEP: Are We There Yet?
por: King-Stephens, David
Publicado: (2019)

A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients
por: Huang, Hai, et al.
Publicado: (2023)

Capacity building in endometriosis ultrasound: are we there yet?
por: Menakaya, Uche A
Publicado: (2015)

Digital future in perioperative medicine: Are we there yet?
por: Panchagnula, Umakanth, et al.
Publicado: (2019)

Molecular Diagnosis in 100% of Dystrophinopathies: Are We There Yet?
por: Pegoraro, Elena
Publicado: (2021)

Radiofrequency ablation for primary hyperparathyroidism: are we there yet?
por: McManus, Catherine
Publicado: (2023)

Urine Biomarkers for the Early Detection of Ovarian Cancer – Are We There Yet?
por: Grayson, Kelly, et al.
Publicado: (2019)

Are we following the guidelines on non-muscle invasive bladder cancer?
por: Reis, Leonardo Oliveira, et al.
Publicado: (2016)

Is experience with extracorporeal urinary diversion following robotic assisted radical cystectomy necessary before transitioning to intracorporeal urinary diversion?
por: Tan, Wei Shen, et al.
Publicado: (2018)

Where are we now and where are we heading in muscle invasive bladder cancer
por: Ku, Ja Hyeon, et al.
Publicado: (2020)

Acute Stroke Biomarkers: Are We There Yet?
por: Dagonnier, Marie, et al.
Publicado: (2021)

The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer
por: Vrieling, Alina
Publicado: (2018)

Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?
por: Hurle, Rodolfo, et al.
Publicado: (2020)

Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
por: Cheng, Xiangming, et al.
Publicado: (2018)

Estrogen, estrogen receptors, and hepatocellular carcinoma: Are we there yet?
por: Sukocheva, Olga A
Publicado: (2018)

Abandoned embryos in Brazil: advances in the decisions. Are we there yet?
por: de Souza, Maria do Carmo Borges, et al.
Publicado: (2018)

Are We There Yet? Emerging Milestones in Aortic Dissection Care
por: Svensson, Lars G.
Publicado: (2019)

Are we there yet? Pushing the boundaries of endonasal surgery into the brainstem
por: Cohen-Gadol, Aaron A.
Publicado: (2020)

Drug Therapy for Obstructive Sleep Apnea: Are We There Yet?
por: Schmickl, Christopher N., et al.
Publicado: (2022)

Upper Tract Urothelial Carcinoma in the Genetically Predisposed Patient: Role of Urinary Markers in Predicting Recurrence
por: Tan, Wei Phin, et al.
Publicado: (2016)

Adherence to statin therapy: it seems we know everything, yet we do nothing
por: Banach, Maciej, et al.
Publicado: (2022)

Biomarkers in renal cell carcinoma: Are we there yet?
por: Gulati, Shuchi, et al.
Publicado: (2021)

World AIDS Day 2007: AIDS at 26, are we there yet?
por: Jeang, Kuan-Teh
Publicado: (2007)

Tbx18 and the generation of a biological pacemaker. Are we there yet?
por: Brand, Thomas
Publicado: (2016)

Optimizing RV lead position in RV cardiomyopathy: Are we there yet?
por: Sharma, Apurva, et al.
Publicado: (2019)

Evidence on technology-driven preoperative exercise interventions: are we there yet?
por: Steffens, Daniel, et al.
Publicado: (2020)

Radiomics-based Management of Indeterminate Lung Nodules? Are We There Yet?
por: Peikert, Tobias, et al.
Publicado: (2020)

Defining the Clinical Utility of the Lung Clearance Index. Are We There Yet?
por: Spano, Jacquelyn, et al.
Publicado: (2021)

PHorecasting Heritable Pulmonary Arterial Hypertension: Are We Nearly There Yet?
por: Aldred, Micheala A.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9qq1ihebap6clmf46u0io92llo